Biotech Nobel winners in discovery race for RNAi therapies

06/7/2007 | Bloomberg

Two Boston-area biotechs, each headed by a Nobel Prize winner, are working to be the first to develop therapies using RNAi discovery. Philip Sharp, head of Alnylam Pharmaceuticals, is working in competition with Craig Mello's RXi Pharmaceuticals.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC